The Roche Commitment 

Since 1991, Roche has invested hundreds of millions of dollars in research and development to accelerate the development of PCR technology, with an emphasis on practical applications with direct benefits to healthcare.

The Roche commitment has included several million dollars in grants to academic institutions, government laboratories, and non-profit organizations for PCR-related research, as well as the continuing dedication of more than 250 Roche scientists and engineers devoted exclusively to the further development of the technology.

Roche retains a focus on six distinct areas—virology, blood screening, women's health, microbiology, oncology, and genomics. The company's automation technology platforms seek to enable the emergence of a brand-new diagnostics industry by making PCR analysis faster, less expensive, and more accessible, with broader-reaching applications.